— Know what they know.
Not Investment Advice

NRXS AMEX

NeurAxis, Inc.
1W: -11.0% 1M: -1.1% 3M: +34.4% YTD: +66.6% 1Y: +86.2%
$7.38
-0.05 (-0.67%)
 
Weekly Expected Move ±9.6%
$6 $7 $8 $9 $9
AMEX · Healthcare · Biotechnology · Alpha Radar Neutral · Power 51 · $91.4M mcap · 8M float · 2.28% daily turnover · Short 51% of daily vol
Smart Money Score
Bullish 75
Insider+$1.0M
Congress
ETF Holdings
Key Statistics
Market Cap$91.4M
52W Range2.196-9.33
Volume93,435
Avg Volume193,048
Beta1.48
Dividend
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOBrian Carrico
Employees21
SectorHealthcare
IndustryBiotechnology
IPO Date2023-08-09
11550 North Meridian Street
Carmel, IN 46032
US
(812) 689-0791
About NeurAxis, Inc.

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Recent Insider Trades

NameTypeSharesPriceDate
Aharon Gil A-Award 221,917 2026-04-28
Aharon Gil A-Award 12,304 2026-04-28
Henrichs Timothy Rob P-Purchase 7,593 $1.96 2026-04-01
Carrico Thomas Joese P-Purchase 667 $1.96 2026-04-01
Carrico Brian Allen P-Purchase 8,060 $1.96 2026-04-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms